Class	O
II	O
transactivator-independent	O
endothelial	O
cell	O
MHC	B-protein
class	I-protein
II	I-protein
gene	O
activation	O
induced	O
by	O
lymphocyte	O
adhesion	O
.	O

NK	O
cells	O
induce	O
MHC	B-protein
class	I-protein
II	I-protein
molecules	O
on	O
the	O
surface	O
of	O
allogeneic	O
endothelial	O
cells	O
in	O
an	O
adhesion-dependent	O
,	O
IFN-gamma	B-protein
-independent	O
manner	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
NK	B-cell_line
cells	I-cell_line
induce	O
HLA-DR	B-protein
on	O
the	O
surface	O
of	O
a	O
mutant	B-cell_line
cell	I-cell_line
line	I-cell_line
that	O
is	O
defective	O
in	O
IFN-gamma	B-protein
-induced	O
MHC	B-protein
class	I-protein
II	I-protein
expression	O
.	O

RNA	O
analysis	O
in	O
these	O
cells	O
and	O
in	O
a	O
cell	O
line	O
that	O
is	O
defective	O
in	O
class	B-protein
II	I-protein
transactivator	I-protein
(	O
CIITA	B-protein
)	O
demonstrates	O
that	O
NK	O
cell-induced	O
HLA-DR	B-RNA
alpha	I-RNA
mRNA	I-RNA
expression	O
is	O
also	O
CIITA	B-protein
-independent	O
.	O

The	O
Janus	B-cell_line
kinase-1-deficient	I-cell_line
cell	I-cell_line
line	I-cell_line
U4A	I-cell_line
expresses	O
HLA-DR	B-RNA
alpha	I-RNA
mRNA	I-RNA
in	O
response	O
to	O
NK	O
cell	O
activation	O
,	O
and	O
HLA-DR	B-DNA
alpha	I-DNA
promoter	I-DNA
constructs	I-DNA
transfected	O
into	O
these	O
cells	O
are	O
induced	O
by	O
NK	B-cell_line
cells	I-cell_line
but	O
not	O
IFN-gamma	B-protein
.	O

These	O
data	O
indicate	O
that	O
the	O
IFN-gamma	B-protein
-independent	O
component	O
of	O
the	O
target	O
cell	O
HLA-DR	B-protein
expression	O
induced	O
by	O
lymphocyte	O
adhesion	O
uses	O
a	O
signaling	O
pathway	O
that	O
is	O
distinct	O
from	O
the	O
IFN-gamma	B-protein
-dependent	O
mechanism	O
and	O
also	O
suggest	O
that	O
CIITA	B-protein
is	O
not	O
required	O
.	O

Reporter	NULL
Cell	NULL
Lines	NULL
a	NULL
a	NULL
a	NULL
The	NULL
family	NULL
keeps	NULL
growing	NULL
Learn	NULL
more	NULL
3	NULL
<	NULL
.	NULL

<	NULL
e	NULL
]	NULL
(	NULL
ap	NULL
)	NULL
D	NULL
3	NULL
Fes	NULL
The	NULL
Io	NULL
Cutting	NULL
Edge	NULL
:	NULL
Class	NULL
II	NULL
Aﬁ	NULL
ihliiﬁlgﬁillélo	NULL
gy	NULL
Transactivator-Independent	NULL
Endothelial	NULL
Cell	NULL
MHC	NULL
Class	NULL
II	NULL
Gene	NULL
Activation	NULL
Induced	NULL
by	NULL
Lymphocyte	NULL
Adhesion	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Mark	NULL
Collinge	NULL
,	NULL
Ruggero	NULL
Pardi	NULL
and	NULL
Jeffrey	NULL
R.	NULL
Bender	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:1589-1593	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/4/1589	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
31	NULL
articles	NULL
,	NULL
20	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/4/1589.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
(	NULL
CTIDG	NULL
€	NULL
=\	NULL
e	NULL
a	NULL
)	NULL
Cutting	NULL
Edge	NULL
:	NULL
Class	NULL
II	NULL
Transactivator-Independent	NULL
Endothelial	NULL
Cell	NULL
MHC	NULL
Class	NULL
II	NULL
Gene	NULL
Activation	NULL
Induced	NULL
by	NULL
Lymphocyte	NULL
Adhesion	NULL
Mark	NULL
Collinge	NULL
,	NULL
``	NULL
*	NULL
Ruggero	NULL
Pardi	NULL
,	NULL
``	NULL
and	NULL
Jeffrey	NULL
R.	NULL
Bender*	NULL
NK	NULL
cells	NULL
induce	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
allogeneic	NULL
endothelial	NULL
cells	NULL
in	NULL
an	NULL
adhesion-dependent	NULL
,	NULL
IFN-y-independent	NULL
manner	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
NK	NULL
cells	NULL
induce	NULL
HLA-DR	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
a	NULL
mutant	NULL
cell	NULL
line	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
IFN-y-induced	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
.	NULL

RNA	NULL
analysis	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CIITA	NULL
)	NULL
demonstrates	NULL
that	NULL
NK	NULL
cell-induced	NULL
HLA-DRa	NULL
mRNA	NULL
expression	NULL
is	NULL
also	NULL
CHIT	NULL
The	NULL
Janus	NULL
kinase-1-deficient	NULL
cell	NULL
line	NULL
U4A	NULL
expresses	NULL
HLA-DRa	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
NK	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
HLA-DRa	NULL
«	NULL
promoter	NULL
constructs	NULL
transfected	NULL
into	NULL
these	NULL
cells	NULL
are	NULL
induced	NULL
by	NULL
NK	NULL
cells	NULL
but	NULL
not	NULL
IFN-y	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
IFN-y-independent	NULL
component	NULL
of	NULL
the	NULL
target	NULL
cell	NULL
HLA-DR	NULL
expression	NULL
induced	NULL
by	NULL
lymphocyte	NULL
adhesion	NULL
uses	NULL
a	NULL
signaling	NULL
pathway	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
IFN-y-dependent	NULL
mechanism	NULL
and	NULL
also	NULL
suggest	NULL
that	NULL
CIITA	NULL
is	NULL
not	NULL
required	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
1589-1593.	NULL
nducible	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
(	NULL
MHCIN	NULL
)	NULL
®	NULL
molecules	NULL
occurs	NULL
primarily	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
,	NULL
and	NULL
a	NULL
number	NULL
of	NULL
cis-	NULL
and	NULL
trans-activating	NULL
factors	NULL
have	NULL
been	NULL
described	NULL
that	NULL
are	NULL
required	NULL
for	NULL
constitutive	NULL
and	NULL
inducible	NULL
expression	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Resting	NULL
vascular	NULL
endothelial	NULL
cells	NULL
(	NULL
ECs	NULL
)	NULL
do	NULL
not	NULL
express	NULL
MHCII	NULL
molecules	NULL
but	NULL
can	NULL
be	NULL
stimulated	NULL
to	NULL
do	NULL
so	NULL
by	NULL
IFN-y	NULL
and	NULL
*Molecular	NULL
Cardiobiology	NULL
Program	NULL
,	NULL
Division	NULL
of	NULL
Cardiovascular	NULL
Medicine	NULL
,	NULL
and	NULL
the	NULL
Raymond	NULL
and	NULL
Beverly	NULL
Sackler	NULL
Foundation	NULL
Laboratory	NULL
,	NULL
Boyer	NULL
Center	NULL
for	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06536	NULL
;	NULL
and	NULL
*Unit	NULL
of	NULL
Clinical	NULL
Immunology	NULL
,	NULL
Department	NULL
of	NULL
Biological	NULL
and	NULL
Technical	NULL
Research	NULL
,	NULL
San	NULL
Raf-facle	NULL
Scientific	NULL
Institute	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
Received	NULL
for	NULL
publication	NULL
April	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
June	NULL
19	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
RO1	NULL
HL-51231	NULL
(	NULL
to	NULL
J.R.B	NULL
.	NULL
)	NULL

,	NULL
European	NULL
Community	NULL
Biomedicine	NULL
and	NULL
Health	NULL
Program	NULL
Grant	NULL
BMHA4CT950875	NULL
,	NULL
and	NULL
the	NULL
Consiglio	NULL
Nazionale	NULL
delle	NULL
Ricerche	NULL
Biotechnology	NULL
Project	NULL
(	NULL
to	NULL
R.P	NULL
.	NULL
)	NULL

.	NULL

M.C	NULL
.	NULL

is	NULL
an	NULL
Associate	NULL
Research	NULL
Scientist	NULL
of	NULL
the	NULL
Raymond	NULL
and	NULL
Beverly	NULL
Sackler	NULL
Foundation	NULL
,	NULL
and	NULL
J.R.B	NULL
.	NULL

is	NULL
a	NULL
Foundation	NULL
Scholar	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Mark	NULL
Collinge	NULL
,	NULL
Boyer	NULL
Center	NULL
for	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
295	NULL
Congress	NULL
Avenue	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06536-0812	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
mark.collinge	NULL
@	NULL
yale.edu	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
MHCIH	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
;	NULL
EC	NULL
,	NULL
endothelial	NULL
cell	NULL
;	NULL
CITA	NULL
,	NULL
class	NULL
II	NULL
transactivator	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
nt	NULL
,	NULL
nucleotide	NULL
(	NULL
s	NULL
)	NULL
;	NULL
GAPDH	NULL
,	NULL
glyc-craldehyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
RPA	NULL
,	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
;	NULL
HGH	NULL
,	NULL
human	NULL
growth	NULL
hormone	NULL
;	NULL
GAS	NULL
,	NULL
y-activation	NULL
sequence	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
lymphocyte	NULL
adhesion	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

IFN-y	NULL
induction	NULL
of	NULL
MHCII	NULL
requires	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
specifically	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CIITA	NULL
)	NULL
.	NULL

Mutations	NULL
of	NULL
CIITA	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
all	NULL
MHCII-deficient	NULL
cell	NULL
lines	NULL
from	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
complementation	NULL
group	NULL
A.	NULL
CIITA	NULL
expression	NULL
itself	NULL
is	NULL
induced	NULL
by	NULL
IFN-y	NULL
(	NULL
5	NULL
)	NULL
,	NULL
apparently	NULL
via	NULL
the	NULL
Janus	NULL
kinase	NULL
(	NULL
JAK	NULL
)	NULL
-1/STAT-1	NULL
@	NULL
«	NULL
pathway	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

Rather	NULL
than	NULL
binding	NULL
to	NULL
specific	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
MHCII	NULL
promoters	NULL
,	NULL
CIITA	NULL
appears	NULL
to	NULL
interact	NULL
directly	NULL
with	NULL
other	NULL
transac-tivating	NULL
factors	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
are	NULL
the	NULL
most	NULL
efficient	NULL
cellular	NULL
inducers	NULL
of	NULL
EC	NULL
class	NULL
II	NULL
molecules	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Although	NULL
NK	NULL
cells	NULL
are	NULL
competent	NULL
producers	NULL
of	NULL
IFN-y	NULL
,	NULL
NK-mediated	NULL
HLA-DR	NULL
induction	NULL
at	NULL
both	NULL
the	NULL
transcrip-tional	NULL
and	NULL
membrane	NULL
level	NULL
can	NULL
be	NULL
achieved	NULL
in	NULL
an	NULL
IFN-y-independent	NULL
manner	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Direct	NULL
NK	NULL
cell	NULL
to	NULL
EC	NULL
contact	NULL
is	NULL
required	NULL
,	NULL
and	NULL
the	NULL
B	NULL
;	NULL
,	NULL
integrin/ICAM-1	NULL
adhesion	NULL
pathway	NULL
is	NULL
critical	NULL
.	NULL

Additionally	NULL
,	NULL
NK	NULL
cells	NULL
induce	NULL
HLA-DRa	NULL
mRNA	NULL
more	NULL
rapidly	NULL
than	NULL
does	NULL
IFN-y	NULL
(	NULL
12	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
new	NULL
protein	NULL
synthesis	NULL
may	NULL
not	NULL
be	NULL
required	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
HLA-DRa	NULL
expression	NULL
induced	NULL
by	NULL
NK	NULL
cells	NULL
can	NULL
be	NULL
achieved	NULL
not	NULL
only	NULL
in	NULL
an	NULL
IFN-y-independent	NULL
manner	NULL
,	NULL
but	NULL
also	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CIITA	NULL
expression	NULL
.	NULL

HLA-DR	NULL
mRNA	NULL
and	NULL
protein	NULL
were	NULL
induced	NULL
by	NULL
NK	NULL
cells	NULL
in	NULL
mutant	NULL
cell	NULL
lines	NULL
that	NULL
were	NULL
defective	NULL
in	NULL
MHCII	NULL
and	NULL
CHTA	NULL
expression	NULL
.	NULL

Additionally	NULL
,	NULL
HLA-DRa	NULL
promoter	NULL
constructs	NULL
and	NULL
mRNA	NULL
were	NULL
induced	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
that	NULL
was	NULL
deficient	NULL
in	NULL
JAK-1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
regulatory	NULL
kinase	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
CIITA	NULL
induction	NULL
by	NULL
IFN-y	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
a	NULL
pathway	NULL
of	NULL
HLA-DR	NULL
induction	NULL
by	NULL
NK	NULL
cells	NULL
that	NULL
is	NULL
not	NULL
only	NULL
independent	NULL
of	NULL
the	NULL
IFN-yR	NULL
,	NULL
but	NULL
also	NULL
of	NULL
CIITA	NULL
,	NULL
which	NULL
was	NULL
previously	NULL
believed	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
MHCII	NULL
molecules	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
Anti-CD56	NULL
mAb	NULL
was	NULL
obtained	NULL
from	NULL
BioSource	NULL
International	NULL
(	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
IFN-y	NULL
was	NULL
supplied	NULL
by	NULL
Collaborative	NULL
Biomedical	NULL
Products	NULL
(	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
neutralizing	NULL
anti-IFN-y	NULL
was	NULL
purchased	NULL
from	NULL
Genzyme	NULL
(	NULL
Cam-bridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
primers	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
W.	NULL
M.	NULL
Keck	NULL
Foundation	NULL
Biotechnology	NULL
Resource	NULL
Laboratory	NULL
at	NULL
Yale	NULL
University	NULL
(	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

All	NULL
other	NULL
Abs	NULL
and	NULL
reagents	NULL
used	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Cell	NULL
isolation	NULL
and	NULL
culture	NULL
NK	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
leukocyte-enriched	NULL
products	NULL
from	NULL
single	NULL
healthy	NULL
adult	NULL
donors	NULL
;	NULL
the	NULL
products	NULL
were	NULL
obtained	NULL
by	NULL
leukopheresis	NULL
that	NULL
was	NULL
performed	NULL
at	NULL
the	NULL
Yale	NULL
Pheresis	NULL
Unit	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Immunodepletion	NULL
(	NULL
negative	NULL
panning	NULL
)	NULL
led	NULL
to	NULL
NK	NULL
cells	NULL
that	NULL
were	NULL
>	NULL
96	NULL
%	NULL
CD56*	NULL
,	NULL
CD16+*	NULL
,	NULL
CD3~	NULL
.	NULL

Single-donor	NULL
HUVECs	NULL
were	NULL
isolated	NULL
and	NULL
cultured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
and	NULL
used	NULL
at	NULL
less	NULL
than	NULL
passage	NULL
6	NULL
.	NULL

The	NULL
HT-1080	NULL
cell	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1590	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
(	NULL
CCL-121	NULL
)	NULL
and	NULL
maintained	NULL
in	NULL
Eagle	NULL
's	NULL
MEM	NULL
with	NULL
nonessential	NULL
amino	NULL
acids	NULL
and	NULL
Earle	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

The	NULL
2C4	NULL
,	NULL
GZA	NULL
,	NULL
G3A	NULL
,	NULL
and	NULL
U4A	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
George	NULL
R.	NULL
Stark	NULL
(	NULL
Cleveland	NULL
Clinic	NULL
Foundation	NULL
,	NULL
Cleve-land	NULL
,	NULL
OH	NULL
)	NULL
and	NULL
maintained	NULL
in	NULL
high	NULL
glucose	NULL
DMEM	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

Membrane	NULL
HLA-DR	NULL
induction	NULL
assays	NULL
and	NULL
flow	NULL
cytometry	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

NK	NULL
cell	NULL
panning	NULL
After	NULL
recovering	NULL
the	NULL
NK	NULL
/target	NULL
cell	NULL
coculture	NULL
from	NULL
plates	NULL
with	NULL
trypsiniza-tion	NULL
,	NULL
the	NULL
panning	NULL
of	NULL
NK	NULL
cells	NULL
away	NULL
from	NULL
target	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
immunodepletion	NULL
with	NULL
anti-CD16	NULL
,	NULL
-CD45	NULL
,	NULL
and	NULL
-CD56	NULL
mAbs	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
purified	NULL
from	NULL
target	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
separated	NULL
from	NULL
NK	NULL
cells	NULL
and	NULL
was	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
(	NULL
see	NULL
below	NULL
)	NULL
with	NULL
primers	NULL
specific	NULL
for	NULL
CD45	NULL
to	NULL
ensure	NULL
complete	NULL
NK	NULL
cell	NULL
depletion	NULL
.	NULL

RNA	NULL
analysis	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
TRIzol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
and	NULL
the	NULL
phase	NULL
lock	NULL
gel	NULL
system	NULL
(	NULL
5	NULL
Prime-3	NULL
Prime	NULL
,	NULL
Boulder	NULL
,	NULL
CO	NULL
)	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
using	NULL
1	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
Superscript	NULL
II	NULL
RNaseH~	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
and	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
5	NULL
primer	NULL
(	NULL
Promega	NULL
,	NULL
Mad-ison	NULL
,	NULL
WI	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturers	NULL
'	NULL
instructions	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
using	NULL
the	NULL
following	NULL
primer	NULL
pairs	NULL
:	NULL
HLA-DR	NULL
«	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
;	NULL
human	NULL
CIITA	NULL
,	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
2881-2901	NULL
and	NULL
3331-3351	NULL
;	NULL
human	NULL
CD45	NULL
,	NULL
nt	NULL
224-244	NULL
and	NULL
1059-1079	NULL
;	NULL
and	NULL
human	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
,	NULL
nt	NULL
12-37	NULL
and	NULL
971-994	NULL
.	NULL

Ribonuclease	NULL
protection	NULL
assay	NULL
(	NULL
RPA	NULL
)	NULL
probes	NULL
were	NULL
generated	NULL
using	NULL
a	NULL
MAXIscript	NULL
kit	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Both	NULL
CIITA	NULL
(	NULL
nt	NULL
3137-3496	NULL
)	NULL
and	NULL
HLA-DRa	NULL
(	NULL
nt	NULL
119-592	NULL
)	NULL
fragments	NULL
in	NULL
pBluescript	NULL
(	NULL
Strat-agene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
transcribed	NULL
using	NULL
T7	NULL
polymerase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
«	NULL
-*PJuridine	NULL
triphosphate	NULL
(	NULL
800	NULL
Ci/mmol	NULL
)	NULL
(	NULL
DuPont	NULL
New	NULL
England	NULL
Nu-clear	NULL
,	NULL
Wilmington	NULL
,	NULL
DE	NULL
)	NULL
.	NULL

RPA	NULL
was	NULL
performed	NULL
using	NULL
total	NULL
cellular	NULL
RNA	NULL
and	NULL
a	NULL
RPAII	NULL
kit	NULL
(	NULL
Ambion	NULL
)	NULL
.	NULL

Plasmid	NULL
constructs	NULL
The	NULL
HLA-DRa	NULL
promoter	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
HGH	NULL
)	NULL
constructs	NULL
that	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Richard	NULL
Flavell	NULL
(	NULL
Yale	NULL
University	NULL
)	NULL
have	NULL
been	NULL
used	NULL
by	NULL
us	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
pGL2	NULL
control	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
cotransfected	NULL
as	NULL
a	NULL
normalization	NULL
control	NULL
.	NULL

Transient	NULL
transfections	NULL
Cells	NULL
that	NULL
had	NULL
been	NULL
plated	NULL
to	NULL
50	NULL
%	NULL
confluence	NULL
were	NULL
transfected	NULL
for	NULL
8	NULL
h	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
using	NULL
a	NULL
calcium	NULL
phosphate	NULL
transfection	NULL
protocol	NULL
(	NULL
14	NULL
)	NULL
.	NULL

After	NULL
glycerol	NULL
shock	NULL
,	NULL
cells	NULL
were	NULL
fed	NULL
fresh	NULL
medium	NULL
and	NULL
left	NULL
overnight	NULL
to	NULL
recover	NULL
.	NULL

Fresh	NULL
medium	NULL
,	NULL
medium	NULL
containing	NULL
100	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
,	NULL
or	NULL
allogeneic	NULL
NK	NULL
cells	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
48	NULL
h.	NULL
The	NULL
HGH	NULL
secreted	NULL
into	NULL
the	NULL
medium	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
*°	NULL
[	NULL
-HGH	NULL
radioimmunoassay	NULL
kit	NULL
(	NULL
Nichols	NULL
Institute	NULL
,	NULL
San	NULL
Juan	NULL
Capistrano	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
HGH	NULL
that	NULL
normalized	NULL
to	NULL
luciferase	NULL
activity	NULL
in	NULL
cell	NULL
extracts	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
luciferase	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
a	NULL
Lumat	NULL
LB	NULL
9501	NULL
(	NULL
Berthold	NULL
,	NULL
Wildbad	NULL
,	NULL
Ger-many	NULL
)	NULL
luminometer	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
We	NULL
demonstrated	NULL
previously	NULL
that	NULL
allogeneic	NULL
NK	NULL
cells	NULL
induce	NULL
MHCII	NULL
molecules	NULL
on	NULL
resting	NULL
ECs	NULL
in	NULL
an	NULL
IFN-y-independent	NULL
,	NULL
adhesion-dependent	NULL
manner	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
involved	NULL
signaling	NULL
path-ways	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
a	NULL
series	NULL
of	NULL
cell	NULL
lines	NULL
that	NULL
had	NULL
been	NULL
rendered	NULL
MHCII-deficient	NULL
by	NULL
chemical	NULL
mutagenesis	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
line	NULL
2C4	NULL
,	NULL
which	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
fibrosarcoma	NULL
cell	NULL
line	NULL
HT-1080	NULL
,	NULL
was	NULL
mutagenized	NULL
with	NULL
ICR-191	NULL
;	NULL
clones	NULL
were	NULL
selected	NULL
that	NULL
do	NULL
not	NULL
express	NULL
surface	NULL
MHCII	NULL
molecules	NULL
either	NULL
at	NULL
rest	NULL
or	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
.	NULL

One	NULL
such	NULL
cell	NULL
line	NULL
,	NULL
GZA	NULL
,	NULL
shows	NULL
partial	NULL
HLA-DRa	NULL
promoter	NULL
occupancy	NULL
,	NULL
and	NULL
MHCII	NULL
expression	NULL
can	NULL
be	NULL
complemented	NULL
by	NULL
an	NULL
overexpression	NULL
of	NULL
CIITA	NULL
(	NULL
K.	NULL
Wright	NULL
and	NULL
J.	NULL
Ting	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

We	NULL
treated	NULL
2C4	NULL
and	NULL
GZA	NULL
with	NULL
either	NULL
250	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
or	NULL
allogeneic	NULL
NK	NULL
cells	NULL
(	NULL
20:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
)	NULL
for	NULL
72	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
membrane	NULL
HLA-DR	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
that	NULL
both	NULL
IFN-y	NULL
and	NULL
NK	NULL
cells	NULL
induce	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
HLA-DR	NULL
in	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
2C4	NULL
.	NULL

As	NULL
CUTTING	NULL
EDGE	NULL
&	NULL
w	NULL
7	NULL
2CA/+IFN-y	NULL
2C4/+NK	NULL
cle	NULL
o	NULL
:	NULL
203	NULL
©	NULL
0	NULL
.	NULL

U	NULL
'	NULL
omg	NULL
omg	NULL
.	NULL

10°	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
10°	NULL
100	NULL
10	NULL
``	NULL
100	NULL
10	NULL
FL2-Height	NULL
FL2-Height	NULL
B	NULL
D	NULL
&	NULL
&	NULL
w	NULL
3	NULL
u	NULL
1	NULL
G2A/+IFN-y	NULL
G2A/+NK	NULL
1	NULL
if	NULL
3	NULL
5	NULL
3	NULL
¢	NULL
o	NULL
o	NULL
4	NULL
13	NULL
3	NULL
©	NULL
En	NULL
``	NULL
``	NULL
``	NULL
'I1	NULL
``	NULL
``	NULL
``	NULL
'	NULL
2	NULL
``	NULL
``	NULL
``	NULL
'	NULL
3	NULL
``	NULL
``	NULL
'	NULL
4	NULL
©	NULL
n	NULL
(	NULL
3	NULL
C4	NULL
10°	NULL
100	NULL
10°	NULL
10	NULL
10	NULL
10	NULL
10°	NULL
10°	NULL
10	NULL
10	NULL
FL2-Height	NULL
FL2-Height	NULL
FIGURE	NULL
1	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
NK	NULL
cell-induced	NULL
membrane	NULL
HLA-DR	NULL
on	NULL
IFN-y-signaling	NULL
mutant	NULL
GZA	NULL
cells	NULL
.	NULL

Confluent	NULL
monolayers	NULL
of	NULL
parental	NULL
2C4	NULL
cells	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
and	NULL
IFN-y-signaling	NULL
mutant	NULL
GZA	NULL
cells	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
were	NULL
pretreated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
medium	NULL
containing	NULL
250	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
or	NULL
allogeneic	NULL
NK	NULL
cells	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
at	NULL
a	NULL
20:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
including	NULL
saturating	NULL
quantities	NULL
of	NULL
anti-IFN-y	NULL
Abs	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
72	NULL
h	NULL
and	NULL
stained	NULL
with	NULL
anti-HLA-DR-phycoerythrin	NULL
.	NULL

In	NULL
the	NULL
coculture	NULL
samples	NULL
,	NULL
NK	NULL
cells	NULL
were	NULL
gated	NULL
out	NULL
with	NULL
simultaneous	NULL
anti-CD45-FITC	NULL
staining	NULL
,	NULL
which	NULL
eliminated	NULL
NK	NULL
cell	NULL
HLA-DR.	NULL
All	NULL
curves	NULL
represent	NULL
the	NULL
membrane	NULL
HLA-DR	NULL
expressed	NULL
in	NULL
5000	NULL
cytometer-acquired	NULL
target	NULL
cells	NULL
.	NULL

described	NULL
earlier	NULL
,	NULL
IFN-y	NULL
failed	NULL
to	NULL
induce	NULL
HLA-DR	NULL
in	NULL
the	NULL
G2A	NULL
cell	NULL
line	NULL
,	NULL
but	NULL
GZA	NULL
retained	NULL
NK	NULL
cell	NULL
responsiveness	NULL
with	NULL
a	NULL
significant	NULL
induction	NULL
of	NULL
membrane	NULL
HLA-DR	NULL
when	NULL
cocultured	NULL
with	NULL
NK	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
observations	NULL
of	NULL
IFN-y-independent	NULL
,	NULL
endothelial	NULL
HLA-DR	NULL
induction	NULL
by	NULL
NK	NULL
cells	NULL
and	NULL
also	NULL
provided	NULL
a	NULL
system	NULL
whereby	NULL
this	NULL
phenomenon	NULL
could	NULL
be	NULL
analyzed	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

In	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
constitutively	NULL
express	NULL
class	NULL
II	NULL
molecules	NULL
,	NULL
MHCII	NULL
gene	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
.	NULL

HLA-DRa	NULL
gene	NULL
transcription	NULL
is	NULL
not	NULL
directly	NULL
and	NULL
immediately	NULL
induced	NULL
by	NULL
IFN-y	NULL
,	NULL
but	NULL
does	NULL
require	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
specifically	NULL
of	NULL
CITA	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
EC	NULL
HLA-DRa	NULL
mRNA	NULL
induction	NULL
by	NULL
allogeneic	NULL
NK	NULL
cells	NULL
are	NULL
faster	NULL
than	NULL
those	NULL
by	NULL
IFN-y	NULL
(	NULL
12	NULL
)	NULL
,	NULL
which	NULL
led	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
newly	NULL
synthesized	NULL
CIITA	NULL
is	NULL
required	NULL
for	NULL
HLA-DRa	NULL
induction	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

We	NULL
again	NULL
took	NULL
advantage	NULL
of	NULL
the	NULL
class	NULL
II-negative	NULL
GZA	NULL
cell	NULL
line	NULL
and	NULL
of	NULL
an	NULL
additional	NULL
cell	NULL
line	NULL
,	NULL
G3A	NULL
,	NULL
that	NULL
had	NULL
been	NULL
generated	NULL
by	NULL
the	NULL
same	NULL
means	NULL
;	NULL
G3A	NULL
is	NULL
CIITA	NULL
and	NULL
class	NULL
II	NULL
negative	NULL
and	NULL
is	NULL
complemented	NULL
to	NULL
wild-type	NULL
IFN-y-mediated	NULL
MHCII	NULL
inducibility	NULL
by	NULL
expression	NULL
of	NULL
rCIITA	NULL
(	NULL
16	NULL
)	NULL
.	NULL

HUVECs	NULL
and	NULL
2C4	NULL
,	NULL
GZA	NULL
,	NULL
and	NULL
G3A	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
8	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
100	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
or	NULL
NK	NULL
cells	NULL
(	NULL
12:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
)	NULL
.	NULL

For	NULL
the	NULL
NK	NULL
cell	NULL
treatments	NULL
,	NULL
the	NULL
responder	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
anti-IFN-yR	NULL
Ab	NULL
,	NULL
and	NULL
anti-IFN-y-neutralizing	NULL
Abs	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
coculture	NULL
.	NULL

Following	NULL
the	NULL
treatments	NULL
,	NULL
NK	NULL
cells	NULL
were	NULL
removed	NULL
through	NULL
Ab	NULL
panning	NULL
;	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
target	NULL
cells	NULL
and	NULL
analyzed	NULL
for	NULL
CIITA	NULL
and	NULL
HLA-DRa	NULL
«	NULL
mRNA	NULL
expression	NULL
by	NULL
RPA	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

CIITA	NULL
and	NULL
HLA-DRa	NULL
mRNA	NULL
was	NULL
absent	NULL
in	NULL
control	NULL
resting	NULL
cells	NULL
,	NULL
except	NULL
for	NULL
a	NULL
trace	NULL
amount	NULL
of	NULL
HLA-DRa	NULL
in	NULL
the	NULL
cell	NULL
line	NULL
2C4	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
IFN-y	NULL
significantly	NULL
up-regulated	NULL
HLA-DRa	NULL
and	NULL
CITA	NULL
mRNA	NULL
in	NULL
HUVECs	NULL
and	NULL
2C4	NULL
.	NULL

In	NULL
the	NULL
GZA	NULL
and	NULL
G3A	NULL
cell	NULL
lines	NULL
,	NULL
there	NULL
was	NULL
a	NULL
small	NULL
but	NULL
detectable	NULL
level	NULL
of	NULL
HLA-DRa	NULL
mRNA	NULL
induction	NULL
by	NULL
IFN-y	NULL
;	NULL
however	NULL
,	NULL
this	NULL
level	NULL
approximated	NULL
the	NULL
level	NULL
of	NULL
basal	NULL
expression	NULL
in	NULL
the	NULL
2C4	NULL
cell	NULL
line	NULL
.	NULL

A	NULL
low	NULL
level	NULL
of	NULL
CIITA	NULL
mRNA	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
the	NULL
cells	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
that	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
B	NULL
HUVEC	NULL
2C4	NULL
GZA	NULL
_	NULL
G3A	NULL
mf	NULL
41	NULL
1	NULL
>	NULL
€	NULL
>	NULL
+IFNy	NULL
+NK	NULL
Control	NULL
M	NULL
Z	NULL
T	NULL
PBM	NULL
Control	NULL
+IFNy	NULL
+IFNy+aIFNy	NULL
CS	NULL
crra	NULL
HLA-DRa	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Correlation	NULL
of	NULL
HLA-DRa	NULL
and	NULL
CIITA	NULL
mRNA	NULL
induction	NULL
by	NULL
IFN-y	NULL
and	NULL
NK	NULL
cell	NULL
adhesion	NULL
in	NULL
HUVECs	NULL
and	NULL
IFN-y-signaling	NULL
mutants	NULL
.	NULL

A	NULL
,	NULL
Confluent	NULL
HUVECs	NULL
and	NULL
2C4	NULL
,	NULL
GZA	NULL
,	NULL
and	NULL
G3A	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
pretreated	NULL
for	NULL
20	NULL
min	NULL
with	NULL
anti-IFN-yR	NULL
Ab	NULL
were	NULL
incubated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
100	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
or	NULL
allogeneic	NULL
NK	NULL
cells	NULL
(	NULL
12:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
)	NULL
that	NULL
had	NULL
been	NULL
pretreated	NULL
for	NULL
35	NULL
min	NULL
with	NULL
anti-IFN-y-neutralizing	NULL
Ab	NULL
.	NULL

Following	NULL
the	NULL
removal	NULL
of	NULL
NK	NULL
cells	NULL
through	NULL
Ab-mediated	NULL
panning	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
)	NULL
where	NULL
appropriate	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
target	NULL
cells	NULL
;	NULL
25	NULL
ug	NULL
of	NULL
this	NULL
total	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
RPA	NULL
using	NULL
probes	NULL
that	NULL
were	NULL
specific	NULL
for	NULL
CIITA	NULL
or	NULL
HLA-DRa	NULL
.	NULL

B	NULL
,	NULL
A	NULL
total	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
the	NULL
above	NULL
experiment	NULL
was	NULL
reverse	NULL
transcribed	NULL
,	NULL
and	NULL
one-twentieth	NULL
of	NULL
the	NULL
reaction	NULL
mix	NULL
was	NULL
analyzed	NULL
by	NULL
PCR	NULL
using	NULL
primers	NULL
that	NULL
were	NULL
specific	NULL
for	NULL
GAPDH	NULL
,	NULL
CIITA	NULL
,	NULL
HLA-DR	NULL
«	NULL
,	NULL
and	NULL
CD45	NULL
.	NULL

PBMC	NULL
RNA	NULL
that	NULL
had	NULL
been	NULL
reverse	NULL
transcribed	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
CD45	NULL
.	NULL

C	NULL
,	NULL
Confluent	NULL
monolayers	NULL
of	NULL
HUVECs	NULL
were	NULL
incubated	NULL
for	NULL
16	NULL
h	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
,	NULL
medium	NULL
containing	NULL
100	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
,	NULL
or	NULL
medium	NULL
containing	NULL
100	NULL
U/ml	NULL
IFN-y	NULL
that	NULL
had	NULL
been	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
anti-IFN-y-neutralizing	NULL
Abs	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
total	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
and	NULL
analyzed	NULL
by	NULL
PCR	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
CHTA	NULL
and	NULL
HLA-DRa	NULL
«	NULL
.	NULL

were	NULL
treated	NULL
with	NULL
NK	NULL
cells	NULL
showed	NULL
a	NULL
dramatic	NULL
induction	NULL
of	NULL
HLA-DRa	NULL
mRNA	NULL
over	NULL
basal	NULL
levels	NULL
.	NULL

In	NULL
the	NULL
2C4	NULL
,	NULL
GZA	NULL
,	NULL
and	NULL
G3A	NULL
cell	NULL
lines	NULL
,	NULL
this	NULL
increased	NULL
expression	NULL
of	NULL
HLA-DRa	NULL
was	NULL
not	NULL
accompanied	NULL
by	NULL
a	NULL
parallel	NULL
increase	NULL
in	NULL
CIITA	NULL
mRNA	NULL
;	NULL
no	NULL
CHITA	NULL
signal	NULL
was	NULL
detectable	NULL
,	NULL
even	NULL
with	NULL
prolonged	NULL
exposure	NULL
.	NULL

There	NULL
is	NULL
a	NULL
barely	NULL
detectable	NULL
CIITA	NULL
mRNA	NULL
band	NULL
in	NULL
NK-treated	NULL
HUVECs	NULL
that	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
observations	NULL
that	NULL
NK	NULL
cells	NULL
have	NULL
an	NULL
IFN-y	NULL
dependent	NULL
component	NULL
of	NULL
MHCII	NULL
induction	NULL
(	NULL
12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
HLA-DRa	NULL
in	NULL
this	NULL
sample	NULL
exceeds	NULL
that	NULL
seen	NULL
for	NULL
the	NULL
IFN-y-treated	NULL
sample	NULL
,	NULL
in	NULL
which	NULL
there	NULL
is	NULL
substantial	NULL
induction	NULL
of	NULL
1591	NULL
CIITA	NULL
mRNA	NULL
.	NULL

This	NULL
induction	NULL
is	NULL
not	NULL
due	NULL
to	NULL
rapid	NULL
CIITA	NULL
mRNA	NULL
turnover	NULL
or	NULL
to	NULL
unusual	NULL
kinetics	NULL
of	NULL
induction	NULL
,	NULL
as	NULL
no	NULL
significant	NULL
CIITA	NULL
transcript	NULL
levels	NULL
were	NULL
observed	NULL
over	NULL
a	NULL
wide	NULL
time	NULL
range	NULL
(	NULL
1-48	NULL
h	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
HLA-DRa	NULL
mRNA	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
target	NULL
cells	NULL
by	NULL
NK	NULL
cells	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
CHITA	NULL
.	NULL

To	NULL
fully	NULL
demonstrate	NULL
the	NULL
absence	NULL
of	NULL
CIITA	NULL
message	NULL
in	NULL
NK	NULL
cell-induced	NULL
target	NULL
cells	NULL
,	NULL
the	NULL
more	NULL
sensitive	NULL
but	NULL
less	NULL
quantitative	NULL
RT-PCR	NULL
method	NULL
was	NULL
used	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
2B	NULL
and	NULL
confirm	NULL
the	NULL
pattern	NULL
of	NULL
CIITA	NULL
and	NULL
HLA-DRa	NULL
expression	NULL
that	NULL
was	NULL
seen	NULL
by	NULL
RPA	NULL
.	NULL

No	NULL
CIITA	NULL
mRNA	NULL
was	NULL
detected	NULL
by	NULL
PCR	NULL
in	NULL
2C4	NULL
,	NULL
GZA	NULL
,	NULL
or	NULL
G3A	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
NK	NULL
cells	NULL
.	NULL

PCR	NULL
using	NULL
primers	NULL
that	NULL
were	NULL
specific	NULL
for	NULL
CD45	NULL
was	NULL
negative	NULL
,	NULL
confirming	NULL
that	NULL
NK	NULL
mRNA	NULL
was	NULL
absent	NULL
from	NULL
the	NULL
samples	NULL
.	NULL

The	NULL
IFN-y-independent	NULL
component	NULL
of	NULL
the	NULL
NK-mediated	NULL
endothelial	NULL
class	NULL
II	NULL
mRNA	NULL
induction	NULL
is	NULL
variable	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Although	NULL
HLA-DRa	NULL
mRNA	NULL
is	NULL
induced	NULL
by	NULL
NK	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CIITA	NULL
in	NULL
most	NULL
experiments	NULL
,	NULL
CIITA	NULL
mRNA	NULL
is	NULL
sometimes	NULL
noted	NULL
depending	NULL
upon	NULL
the	NULL
NK	NULL
cell	NULL
and	NULL
EC	NULL
donors	NULL
,	NULL
since	NULL
these	NULL
experiments	NULL
are	NULL
conducted	NULL
with	NULL
single-donor	NULL
cells	NULL
for	NULL
both	NULL
allogeneic	NULL
NK	NULL
cells	NULL
and	NULL
ECs	NULL
.	NULL

Figure	NULL
2C	NULL
demonstrates	NULL
that	NULL
the	NULL
IFN-y-neutralizing	NULL
Abs	NULL
used	NULL
in	NULL
the	NULL
NK	NULL
cell	NULL
activation	NULL
experiments	NULL
completely	NULL
inhibit	NULL
EC	NULL
CIITA	NULL
and	NULL
HLA-DRa	NULL
mRNA	NULL
induction	NULL
by	NULL
IFN-y	NULL
as	NULL
determined	NULL
by	NULL
PCR	NULL
.	NULL

Adding	NULL
dextran	NULL
sulfate	NULL
to	NULL
ECs	NULL
suppresses	NULL
the	NULL
induction	NULL
of	NULL
CIITA	NULL
and	NULL
MHCII	NULL
gene	NULL
expression	NULL
by	NULL
IFN-y	NULL
(	NULL
17	NULL
)	NULL
.	NULL

We	NULL
are	NULL
able	NULL
to	NULL
reproduce	NULL
these	NULL
results	NULL
and	NULL
show	NULL
that	NULL
NK	NULL
cells	NULL
bind	NULL
to	NULL
vascular	NULL
ECs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dextran	NULL
sulfate	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
HLA-DRa	NULL
mRNA	NULL
is	NULL
induced	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
attempts	NULL
to	NULL
detect	NULL
CIITA	NULL
mRNA	NULL
in	NULL
the	NULL
mutant	NULL
cell	NULL
lines	NULL
that	NULL
were	NULL
cocultured	NULL
with	NULL
NK	NULL
cells	NULL
have	NULL
failed	NULL
,	NULL
suggesting	NULL
an	NULL
alternative	NULL
mechanism	NULL
for	NULL
MHCII	NULL
gene	NULL
activation	NULL
.	NULL

We	NULL
also	NULL
performed	NULL
PCR	NULL
with	NULL
primers	NULL
corresponding	NULL
to	NULL
nt	NULL
235-519	NULL
CIITA	NULL
(	NULL
18	NULL
)	NULL
to	NULL
detect	NULL
CIITA	NULL
mRNA	NULL
species	NULL
that	NULL
may	NULL
contain	NULL
3	NULL
'	NULL
truncations	NULL
.	NULL

The	NULL
experimental	NULL
results	NULL
were	NULL
identical	NULL
with	NULL
the	NULL
PCR	NULL
analysis	NULL
using	NULL
primers	NULL
corresponding	NULL
to	NULL
nt	NULL
2881-3351	NULL
that	NULL
is	NULL
described	NULL
above	NULL
.	NULL

CIITA	NULL
mRNA	NULL
can	NULL
be	NULL
induced	NULL
from	NULL
multiple	NULL
promoters	NULL
depending	NULL
upon	NULL
the	NULL
specific	NULL
cellular	NULL
environment	NULL
;	NULL
at	NULL
least	NULL
four	NULL
promoters	NULL
have	NULL
been	NULL
described	NULL
for	NULL
human	NULL
CHITA	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
expression	NULL
four	NULL
cDNAs	NULL
with	NULL
distinct	NULL
5	NULL
'	NULL
ends	NULL
.	NULL

The	NULL
analysis	NULL
described	NULL
in	NULL
this	NULL
report	NULL
would	NULL
detect	NULL
all	NULL
four	NULL
forms	NULL
of	NULL
CIITA	NULL
.	NULL

Since	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
IFN-y-independent	NULL
induction	NULL
of	NULL
HLA-DRa	NULL
by	NULL
NK	NULL
cells	NULL
is	NULL
also	NULL
independent	NULL
of	NULL
CIITA	NULL
,	NULL
we	NULL
investigated	NULL
other	NULL
molecules	NULL
involved	NULL
in	NULL
IFN-y	NULL
signaling	NULL
.	NULL

JAK-1	NULL
and	NULL
JAK-2	NULL
associate	NULL
directly	NULL
with	NULL
the	NULL
IFN-yR	NULL
;	NULL
upon	NULL
phosphorylation	NULL
,	NULL
these	NULL
kinases	NULL
are	NULL
able	NULL
to	NULL
phosphorylate	NULL
and	NULL
activate	NULL
STAT-1	NULL
«	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

21	NULL
)	NULL
.	NULL

STAT-1	NULL
@	NULL
then	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
binds	NULL
a	NULL
y-activation	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
or	NULL
GAS-like	NULL
elements	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
IFN-y-activated	NULL
primary	NULL
response	NULL
genes	NULL
.	NULL

At	NULL
least	NULL
one	NULL
of	NULL
the	NULL
promoters	NULL
for	NULL
CHTA	NULL
contains	NULL
a	NULL
GAS-like	NULL
element	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Suppression	NULL
of	NULL
STAT-1	NULL
«	NULL
expression	NULL
inhibits	NULL
IFN-y-stimulated	NULL
CITA	NULL
mRNA	NULL
expression	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Since	NULL
our	NULL
coculture	NULL
experiments	NULL
used	NULL
anti-IFN-y	NULL
and	NULL
anti-IFN-yR	NULL
Abs	NULL
and	NULL
since	NULL
CIITA	NULL
was	NULL
not	NULL
induced	NULL
in	NULL
target	NULL
cells	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
JAK-1	NULL
was	NULL
required	NULL
.	NULL

The	NULL
U4A	NULL
cell	NULL
line	NULL
(	NULL
22	NULL
)	NULL
is	NULL
defective	NULL
in	NULL
IFN-y	NULL
signaling	NULL
and	NULL
expresses	NULL
truncated	NULL
JAK-1	NULL
mRNA	NULL
and	NULL
protein	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
used	NULL
U4A	NULL
in	NULL
our	NULL
coculture	NULL
system	NULL
to	NULL
determine	NULL
whether	NULL
JAK-1	NULL
was	NULL
required	NULL
to	NULL
obtain	NULL
HLA-DRa	NULL
induction	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

IFN-y	NULL
(	NULL
100	NULL
U/m	NULL
!	NULL
)	NULL

or	NULL
NK	NULL
cells	NULL
(	NULL
5:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
)	NULL
were	NULL
added	NULL
to	NULL
confluent	NULL
cultures	NULL
of	NULL
the	NULL
U4A	NULL
cell	NULL
line	NULL
or	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
HT-1080	NULL
and	NULL
incubated	NULL
for	NULL
16	NULL
h.	NULL
Following	NULL
the	NULL
removal	NULL
of	NULL
NK	NULL
cells	NULL
by	NULL
Ab-mediated	NULL
panning	NULL
,	NULL
target	NULL
cell	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

No	NULL
basal	NULL
HLA-DRa	NULL
message	NULL
was	NULL
detected	NULL
in	NULL
either	NULL
cell	NULL
line	NULL
,	NULL
but	NULL
IFN-y	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
both	NULL
CIITA	NULL
and	NULL
HLA-DRa	NULL
message	NULL
in	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
HT-1080	NULL
;	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1592	NULL
HT1080	NULL
U4A	NULL
1	NULL
;	NULL
£5	NULL
#	NULL
2	NULL
z	NULL
9	NULL
2	NULL
guo	NULL
ﬂifgg	NULL
‘	NULL
f	NULL
‘	NULL
ﬁx	NULL
o	NULL
%	NULL
a	NULL
23	NULL
T2	NULL
74	NULL
8	NULL
F	NULL
z-	NULL
]	NULL
400,000	NULL
300,000	NULL
200,000	NULL
100,000	NULL
~	NULL
Normalized	NULL
CPM	NULL
(	NULL
L°T-HGH	NULL
)	NULL
<	NULL
€4-HT1080	NULL
--	NULL
-	NULL
4-144	NULL
-	NULL
#	NULL
FIGURE	NULL
3	NULL
.	NULL

Induction	NULL
of	NULL
HLA-DRa	NULL
mRNA	NULL
and	NULL
promoter	NULL
constructs	NULL
by	NULL
NK	NULL
cell	NULL
adhesion	NULL
to	NULL
JAK-1l-deficient	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Confluent	NULL
cultures	NULL
of	NULL
HT1080	NULL
and	NULL
U4A	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
16	NULL
h	NULL
in	NULL
either	NULL
medium	NULL
alone	NULL
,	NULL
medium	NULL
containing	NULL
100	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
,	NULL
or	NULL
medium	NULL
containing	NULL
NK	NULL
cells	NULL
(	NULL
5:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
Ab-mediated	NULL
panning	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
target	NULL
cells	NULL
,	NULL
reverse	NULL
transcribed	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
PCR	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
GAPDH	NULL
,	NULL
CITA	NULL
,	NULL
HLA-DRa	NULL
,	NULL
and	NULL
CD45	NULL
.	NULL

B	NULL
,	NULL
HT-1080	NULL
and	NULL
U4A	NULL
(	NULL
50	NULL
%	NULL
confluent	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
each	NULL
of	NULL
plasmids	NULL
-269DR	NULL
&	NULL
/HGH	NULL
and	NULL
pGL2-luciferase	NULL
control	NULL
vector	NULL
.	NULL

After	NULL
20	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
medium	NULL
containing	NULL
100	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
,	NULL
or	NULL
medium	NULL
containing	NULL
NK	NULL
cells	NULL
(	NULL
5:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
The	NULL
medium	NULL
was	NULL
assayed	NULL
in	NULL
duplicate	NULL
for	NULL
HGH	NULL
expression	NULL
from	NULL
the	NULL
-269DR	NULL
&	NULL
/HGH	NULL
construct	NULL
and	NULL
was	NULL
normalized	NULL
to	NULL
luciferase	NULL
activity	NULL
in	NULL
cellular	NULL
extracts	NULL
.	NULL

neither	NULL
message	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
JAK-1-deficient	NULL
U4A	NULL
.	NULL

However	NULL
,	NULL
NK	NULL
cells	NULL
induced	NULL
HLA-DRa	NULL
mRNA	NULL
in	NULL
both	NULL
the	NULL
HT-1080	NULL
and	NULL
U4A	NULL
cell	NULL
lines	NULL
;	NULL
CIITA	NULL
message	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
either	NULL
case	NULL
.	NULL

It	NULL
appears	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
HLA-DRa	NULL
mRNA	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
NK	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
both	NULL
CHITA	NULL
and	NULL
JAK-1	NULL
,	NULL
which	NULL
indicates	NULL
a	NULL
completely	NULL
divergent	NULL
pathway	NULL
of	NULL
IFN-y-independent	NULL
induction	NULL
of	NULL
HLA-DRa	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
observation	NULL
,	NULL
a	NULL
HGH	NULL
construct	NULL
containing	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
HLA-DRa	NULL
promoter	NULL
(	NULL
-269	NULL
HLA-DRa	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
these	NULL
cell	NULL
lines	NULL
along	NULL
with	NULL
a	NULL
luciferase	NULL
normalization	NULL
plasmid	NULL
;	NULL
cells	NULL
were	NULL
then	NULL
activated	NULL
with	NULL
either	NULL
NK	NULL
cells	NULL
or	NULL
IFN-y	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
3B	NULL
.	NULL

In	NULL
both	NULL
the	NULL
HT-1080	NULL
and	NULL
U4A	NULL
cell	NULL
lines	NULL
,	NULL
there	NULL
is	NULL
always	NULL
substantial	NULL
basal	NULL
HGH	NULL
expression	NULL
from	NULL
this	NULL
promoter	NULL
construct	NULL
.	NULL

In	NULL
the	NULL
HT-1080	NULL
cell	NULL
line	NULL
,	NULL
IFN-y	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
5:1	NULL
NK	NULL
:	NULL
responder	NULL
ratio	NULL
)	NULL
induced	NULL
the	NULL
promoter	NULL
(	NULL
6.2-	NULL
and	NULL
3.6-fold	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
U4A	NULL
cell	NULL
line	NULL
,	NULL
IFN-y	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
promoter	NULL
construct	NULL
;	NULL
there	NULL
was	NULL
a	NULL
2.5-fold	NULL
induction	NULL
with	NULL
NK	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
RT-PCR	NULL
data	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
.	NULL

It	NULL
is	NULL
apparent	NULL
that	NULL
NK	NULL
cells	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
HLA-DRa	NULL
in	NULL
target	NULL
cells	NULL
independently	NULL
of	NULL
CHITA	NULL
using	NULL
a	NULL
pathway	NULL
that	NULL
is	NULL
CUTTING	NULL
EDGE	NULL
completely	NULL
divergent	NULL
from	NULL
IFN-y	NULL
induction	NULL
,	NULL
since	NULL
Abs	NULL
that	NULL
neutralize	NULL
IFN-y	NULL
and	NULL
also	NULL
block	NULL
IFN-yR	NULL
have	NULL
no	NULL
effect	NULL
,	NULL
and	NULL
JAK-1	NULL
kinase	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
IFN-y	NULL
response	NULL
,	NULL
can	NULL
be	NULL
circum-vented	NULL
.	NULL

Whether	NULL
another	NULL
trans-activating	NULL
factor	NULL
is	NULL
induced	NULL
by	NULL
NK	NULL
cell	NULL
activation	NULL
and	NULL
can	NULL
act	NULL
independently	NULL
of	NULL
CIITA	NULL
or	NULL
whether	NULL
a	NULL
more	NULL
direct	NULL
signaling	NULL
event	NULL
is	NULL
involved	NULL
is	NULL
under	NULL
investigation	NULL
.	NULL

HLA-DRa	NULL
mRNA	NULL
induction	NULL
is	NULL
more	NULL
rapid	NULL
with	NULL
NK	NULL
cell	NULL
stimulation	NULL
compared	NULL
with	NULL
the	NULL
induction	NULL
observed	NULL
with	NULL
IFN-y	NULL
stimulation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Perhaps	NULL
a	NULL
more	NULL
direct	NULL
signaling	NULL
event	NULL
is	NULL
involved	NULL
,	NULL
with	NULL
post-translational	NULL
modification	NULL
of	NULL
a	NULL
preexisting	NULL
but	NULL
as	NULL
yet	NULL
unknown	NULL
fac-tor	NULL
.	NULL

Direct	NULL
contact	NULL
through	NULL
B	NULL
,	NULL
integrin/ICAM-1	NULL
adhesion	NULL
is	NULL
required	NULL
to	NULL
achieve	NULL
IFN-y-independent	NULL
induction	NULL
(	NULL
12	NULL
)	NULL
.	NULL

ICAM-1	NULL
cross-linking	NULL
can	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
and	NULL
induce	NULL
MHCII	NULL
membrane	NULL
expression	NULL
on	NULL
A20	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
may	NULL
trigger	NULL
ICAM-1-mediated	NULL
signal	NULL
transduction	NULL
via	NULL
adhesion	NULL
,	NULL
resulting	NULL
in	NULL
HLA-DRa	NULL
«	NULL
gene	NULL
activation	NULL
.	NULL

According	NULL
to	NULL
DNA	NULL
footprinting	NULL
analysis	NULL
,	NULL
the	NULL
HLA-DRa	NULL
promoter	NULL
in	NULL
the	NULL
G3	NULL
cell	NULL
line	NULL
(	NULL
CIHITA-defective	NULL
)	NULL
is	NULL
completely	NULL
bare	NULL
;	NULL
however	NULL
,	NULL
this	NULL
promoter	NULL
is	NULL
partially	NULL
occupied	NULL
in	NULL
the	NULL
GZA	NULL
cell	NULL
line	NULL
(	NULL
K.	NULL
Wright	NULL
and	NULL
J.	NULL
Ting	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

Efforts	NULL
are	NULL
un-derway	NULL
to	NULL
compare	NULL
IFN-y-	NULL
and	NULL
NK	NULL
cell-induced	NULL
footprints	NULL
in	NULL
these	NULL
mutant	NULL
cell	NULL
lines	NULL
as	NULL
well	NULL
as	NULL
in	NULL
ECs	NULL
in	NULL
an	NULL
effort	NULL
to	NULL
identify	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
HLA-DRa	NULL
promoter	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
gene	NULL
activation	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

CIITA	NULL
knockout	NULL
mice	NULL
express	NULL
MHCII	NULL
molecules	NULL
in	NULL
the	NULL
inter-digitating	NULL
reticular	NULL
cells	NULL
of	NULL
the	NULL
thymus	NULL
(	NULL
27	NULL
)	NULL
.	NULL

An	NULL
isotype-specific	NULL
activator	NULL
of	NULL
HLA-DQ	NULL
that	NULL
can	NULL
act	NULL
independently	NULL
of	NULL
CIITA	NULL
has	NULL
been	NULL
proposed	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

There	NULL
is	NULL
precedent	NULL
,	NULL
therefore	NULL
,	NULL
for	NULL
the	NULL
endogenous	NULL
expression	NULL
of	NULL
MHCII	NULL
molecules	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CIITA	NULL
.	NULL

Although	NULL
we	NULL
describe	NULL
an	NULL
IFN-y-independent	NULL
pathway	NULL
,	NULL
accessory	NULL
pathways	NULL
of	NULL
MHCII	NULL
induction	NULL
by	NULL
IFN-y	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
that	NULL
involve	NULL
non-Janus	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Given	NULL
the	NULL
easily	NULL
detectable	NULL
HLA-DRa	NULL
gene	NULL
activation	NULL
in	NULL
the	NULL
U4A	NULL
cell	NULL
line	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
NK	NULL
cell	NULL
adhesion	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
similar	NULL
,	NULL
non-JAK-mediated	NULL
kinase	NULL
pathway	NULL
.	NULL

It	NULL
is	NULL
also	NULL
worth	NULL
noting	NULL
that	NULL
CIITA	NULL
has	NULL
a	NULL
y	NULL
nt-binding	NULL
motif	NULL
that	NULL
appears	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
its	NULL
function	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Other	NULL
GTP-binding	NULL
proteins	NULL
may	NULL
be	NULL
induced	NULL
in	NULL
ECs	NULL
by	NULL
lymphocyte	NULL
adhesion	NULL
,	NULL
by	NULL
replacing	NULL
CIITA	NULL
in	NULL
its	NULL
protein-protein	NULL
interaction	NULL
role	NULL
,	NULL
or	NULL
through	NULL
other	NULL
common	NULL
roles	NULL
of	NULL
GTP-binding	NULL
proteins	NULL
,	NULL
including	NULL
signal	NULL
transduction	NULL
and	NULL
protein	NULL
transport	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
provide	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
inducible	NULL
MHCII	NULL
(	NULL
HLA-DR	NULL
«	NULL
a	NULL
)	NULL
molecules	NULL
can	NULL
be	NULL
expressed	NULL
independently	NULL
of	NULL
CHITA	NULL
.	NULL

While	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
CIITA	NULL
is	NULL
required	NULL
for	NULL
IFN-y	NULL
induction	NULL
of	NULL
MHCII	NULL
molecules	NULL
(	NULL
5	NULL
)	NULL
,	NULL
it	NULL
can	NULL
no	NULL
longer	NULL
be	NULL
viewed	NULL
as	NULL
an	NULL
essential	NULL
regulator	NULL
of	NULL
MHCII	NULL
in	NULL
all	NULL
cellular	NULL
contexts	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
George	NULL
Stark	NULL
and	NULL
Ian	NULL
Kerr	NULL
for	NULL
providing	NULL
the	NULL
IFN-y-signaling	NULL
mutant	NULL
cell	NULL
lines	NULL
and	NULL
Kenneth	NULL
Wright	NULL
and	NULL
Jenny	NULL
Ting	NULL
for	NULL
helpful	NULL
discus-sions	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Lynn	NULL
O'Donnell	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
and	NULL
both	NULL
Louise	NULL
Benson	NULL
and	NULL
Gwen	NULL
Davis	NULL
for	NULL
cell	NULL
culture	NULL
support	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
the	NULL
Milford	NULL
General	NULL
Hospital	NULL
Delivery	NULL
Room	NULL
for	NULL
providing	NULL
umbilical	NULL
cords	NULL
and	NULL
to	NULL
the	NULL
Yale	NULL
Pheresis	NULL
Unit	NULL
and	NULL
Rita	NULL
Girdzis	NULL
for	NULL
assistance	NULL
with	NULL
leukopheresis	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Boss	NULL
,	NULL
J.	NULL
M.	NULL
1997	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:107	NULL
.	NULL

2	NULL
.	NULL

Pardi	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Bender	NULL
.	NULL

1991	NULL
.	NULL

Signal	NULL
requirements	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
CD4	NULL
*	NULL
and	NULL
CD8	NULL
*	NULL
responses	NULL
to	NULL
human	NULL
allogeneic	NULL
microvascular	NULL
endothelium	NULL
.	NULL

Circ	NULL
.	NULL

Res	NULL
.	NULL

69:1269	NULL
.	NULL

3	NULL
.	NULL

Pardi	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
R.	NULL
Bender	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Engelman	NULL
.	NULL

1987	NULL
.	NULL

Lymphocyte	NULL
subsets	NULL
differ-entially	NULL
induce	NULL
class	NULL
II	NULL
human	NULL
leukocyte	NULL
antigens	NULL
on	NULL
allogeneic	NULL
microvascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:2585	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17.	NULL
.	NULL

Pober	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
J.	NULL
Gimbrone	NULL
.	NULL

1982	NULL
.	NULL

Expression	NULL
of	NULL
Ta-like	NULL
antigens	NULL
by	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
is	NULL
inducible	NULL
in	NULL
vitro	NULL
:	NULL
demonstration	NULL
by	NULL
mono-clonal	NULL
antibody	NULL
binding	NULL
and	NULL
immunoprecipitation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:6641.	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
C.-A	NULL
.	NULL

Siegrist	NULL
,	NULL
A.	NULL
Mottet	NULL
,	NULL
B.	NULL
Lisowska-Grospictre	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
by	NULL
interferon-y	NULL
mediated	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
CIITA	NULL
.	NULL

Science	NULL
265:106.	NULL
.	NULL

Chang	NULL
,	NULL
C.-H.	NULL
,	NULL
J.	NULL
D.	NULL
Fontes	NULL
,	NULL
M.	NULL
Peterlin	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

Class	NULL
II	NULL
trans-	NULL
activator	NULL
(	NULL
CIITA	NULL
)	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1367.	NULL
.	NULL

Meraz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
J.	NULL
M.	NULL
White	NULL
,	NULL
K.	NULL
C.	NULL
F.	NULL
Shechan	NULL
,	NULL
E.	NULL
A.	NULL
Bach	NULL
,	NULL
S.	NULL
J.	NULL
Rodig	NULL
,	NULL
A.	NULL
S.	NULL
Dighe	NULL
,	NULL
D.	NULL
H.	NULL
Kaplan	NULL
,	NULL
J.	NULL
K.	NULL
Riley	NULL
,	NULL
A.	NULL
C.	NULL
Greenlund	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
K.	NULL
Carver-Moore	NULL
,	NULL
R.	NULL
DuBois	NULL
,	NULL
R.	NULL
Clark	NULL
,	NULL
M.	NULL
Aguet	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Schreiber	NULL
.	NULL

1996	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
STAT1	NULL
gene	NULL
in	NULL
mice	NULL
reveals	NULL
unexpected	NULL
physiologic	NULL
specificity	NULL
in	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
84:431.	NULL
.	NULL

Lee	NULL
,	NULL
Y.-J	NULL
.	NULL

,	NULL
and	NULL
E.	NULL
N.	NULL
Benveniste	NULL
.	NULL

1996	NULL
.	NULL

Statla	NULL
expression	NULL
is	NULL
involved	NULL
in	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
and	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:1559.	NULL
.	NULL

Scholl	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
K.	NULL
Mahanta	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Strominger	NULL
.	NULL

1997	NULL
.	NULL

Specific	NULL
complex	NULL
forma-	NULL
tion	NULL
between	NULL
the	NULL
type	NULL
II	NULL
bare	NULL
lymphocyte	NULL
syndrome-associated	NULL
transactivators	NULL
CIITA	NULL
and	NULL
RFXS5	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:6330	NULL
.	NULL

Fontes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B.	NULL
Jiang	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
class	NULL
II	NULL
frans-activator	NULL
CIITA	NULL
interacts	NULL
with	NULL
the	NULL
TBP-associated	NULL
factor	NULL
TAFp32	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

25	NULL
:	NULL
2522	NULL
.	NULL

Mahanta	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
T.	NULL
Scholl	NULL
,	NULL
F.-C.	NULL
Yang	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Strominger	NULL
.	NULL

1997	NULL
.	NULL

Transactiva-tion	NULL
by	NULL
CHTA	NULL
,	NULL
the	NULL
type	NULL
II	NULL
bare	NULL
lymphocyte	NULL
syndrome-associated	NULL
factor	NULL
,	NULL
requires	NULL
participation	NULL
of	NULL
multiple	NULL
regions	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:6324	NULL
.	NULL

Watson	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
P.	NULL
Petzelbauer	NULL
,	NULL
J.	NULL
Zhou	NULL
,	NULL
R.	NULL
Pardi	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Bender	NULL
.	NULL

1995	NULL
.	NULL

Contact-dependent	NULL
endothelial	NULL
class	NULL
II	NULL
HLA	NULL
gene	NULL
activation	NULL
induced	NULL
by	NULL
NK	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
IFN-y-dependent	NULL
and	NULL
-independent	NULL
mechanisms	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:3222	NULL
.	NULL

Lanier	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
E.	NULL
G	NULL
.	NULL

Engelman	NULL
.	NULL

,	NULL
P.	NULL
Gatenby	NULL
,	NULL
G.	NULL
F.	NULL
Babcock	NULL
,	NULL
N.	NULL
L.	NULL
Warner	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1983	NULL
.	NULL

Correlation	NULL
of	NULL
functional	NULL
properties	NULL
of	NULL
human	NULL
lymphoid	NULL
cell	NULL
subsets	NULL
and	NULL
surface	NULL
marker	NULL
phenotypes	NULL
using	NULL
multi-parameter	NULL
analysis	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

74:143	NULL
.	NULL

Graham	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
J	NULL
.	NULL

Van	NULL
der	NULL
Eb	NULL
.	NULL

1973	NULL
.	NULL

A	NULL
new	NULL
technique	NULL
for	NULL
the	NULL
assay	NULL
of	NULL
infectivity	NULL
of	NULL
human	NULL
adenovirus	NULL
5	NULL
DNA	NULL
.	NULL

Virology	NULL
52:456	NULL
.	NULL

Mao	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
Davies	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Stark	NULL
.	NULL

1993	NULL
.	NULL

Mutant	NULL
human	NULL
cells	NULL
defective	NULL
in	NULL
induction	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
genes	NULL
by	NULL
interferon	NULL
y.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2880	NULL
.	NULL

Chin	NULL
,	NULL
K.-C.	NULL
,	NULL
C.	NULL
Mao	NULL
,	NULL
C.	NULL
Skinner	NULL
,	NULL
J.	NULL
L.	NULL
Riley	NULL
,	NULL
K.	NULL
L.	NULL
Wright	NULL
,	NULL
C.	NULL
S.	NULL
Moreno	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
J.	NULL
M.	NULL
Boss	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
G1B	NULL
and	NULL
G3A	NULL
IFNy	NULL
mutants	NULL
reveals	NULL
that	NULL
defects	NULL
in	NULL
CIITA	NULL
or	NULL
RFX	NULL
result	NULL
in	NULL
defective	NULL
class	NULL
IL	NULL
MHC	NULL
and	NULL
Ti	NULL
gene	NULL
induction	NULL
.	NULL

Immunity	NULL
1:687	NULL
.	NULL

Lian	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
G.	NULL
J.	NULL
Kotwal	NULL
,	NULL
S.	NULL
R.	NULL
Wellhausen	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

Hunt	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Justus	NULL
.	NULL

1996	NULL
.	NULL

IFN-y-induced	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
is	NULL
suppressed	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
dextran	NULL
sulfate	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:864	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

1593	NULL
Steimle	NULL
,	NULL
V.	NULL
,	NULL
L.	NULL
A.	NULL
Otten	NULL
,	NULL
M.	NULL
Zufferey	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1993	NULL
.	NULL

Complementation	NULL
cloning	NULL
of	NULL
an	NULL
MHC	NULL
class	NULL
II	NULL
transactivator	NULL
mutated	NULL
in	NULL
hereditary	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
(	NULL
or	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
)	NULL
.	NULL

Cell	NULL
75:135	NULL
.	NULL

Lennon	NULL
,	NULL
A.-M.	NULL
,	NULL
C.	NULL
Ottone	NULL
,	NULL
G.	NULL
Rigaud	NULL
,	NULL
L.	NULL
L.	NULL
Deaven	NULL
,	NULL
J.	NULL
Longmire	NULL
,	NULL
M.	NULL
Fellous	NULL
,	NULL
R.	NULL
Bono	NULL
,	NULL
and	NULL
C.	NULL
Alcaide-Loridan	NULL
.	NULL

1997	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
B-cell-specific	NULL
promoter	NULL
for	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
.	NULL

Immunogenetics	NULL
45:266	NULL
.	NULL

Muhlethaler-Mottet	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

Often	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1997	NULL
.	NULL

Expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
in	NULL
different	NULL
cellular	NULL
and	NULL
functional	NULL
compartments	NULL
is	NULL
controlled	NULL
by	NULL
differential	NULL
usage	NULL
of	NULL
multiple	NULL
promoters	NULL
of	NULL
the	NULL
transactivator	NULL
CIITA	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:2851	NULL
.	NULL

Bach	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
M.	NULL
Aguet	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Schreiber	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IFN-y	NULL
receptor	NULL
:	NULL
a	NULL
paradigm	NULL
for	NULL
cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:563	NULL
.	NULL

McKendry	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
John	NULL
,	NULL
D.	NULL
Flavell	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Stark	NULL
.	NULL

1991	NULL
.	NULL

High-frequency	NULL
mutagenesis	NULL
of	NULL
human	NULL
cells	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
mutant	NULL
unresponsive	NULL
to	NULL
both	NULL
a	NULL
and	NULL
-y	NULL
interferons	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:11455	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Briscoe	NULL
,	NULL
C.	NULL
Laxton	NULL
,	NULL
D.	NULL
Guschin	NULL
,	NULL
A.	NULL
Ziemiecki	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
A.	NULL
G.	NULL
Harpur	NULL
,	NULL
G.	NULL
Barbieri	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
S.	NULL
Pellegrini	NULL
,	NULL
A.	NULL
F.	NULL
Wilks	NULL
,	NULL
J.	NULL
N.	NULL
Ihle	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Kerr	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
JAK1	NULL
complements	NULL
defects	NULL
in	NULL
interferon-	NULL
@	NULL
/	NULL
and	NULL
-y	NULL
signal	NULL
transduction	NULL
.	NULL

Nature	NULL
366:129	NULL
.	NULL

Chirthaworn	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
A.	NULL
Tibbetts	NULL
,	NULL
M.	NULL
A.	NULL
Chan	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Benedict	NULL
.	NULL

1995	NULL
.	NULL

Cross-linking	NULL
ICAM-1	NULL
on	NULL
T	NULL
cells	NULL
induces	NULL
transient	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
inac-tivation	NULL
of	NULL
cdc2	NULL
kinase	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:5479	NULL
.	NULL

Durieu-Trautmann	NULL
,	NULL
O.	NULL
,	NULL
N.	NULL
Chaverot	NULL
,	NULL
S.	NULL
Cazaubon	NULL
,	NULL
A.	NULL
D.	NULL
Strosberg	NULL
,	NULL
and	NULL
P.-O	NULL
.	NULL

Couraud	NULL
.	NULL

1994	NULL
.	NULL

Intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
activation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
cytoskeleton-associated	NULL
protein	NULL
cortactin	NULL
in	NULL
brain	NULL
microvessel	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:12536	NULL
.	NULL

Holland	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Owens	NULL
.	NULL

1997	NULL
.	NULL

Signaling	NULL
through	NULL
intercellular	NULL
adhesion	NULL
mol-ecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
lymphoma	NULL
line	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:9108	NULL
.	NULL

Chang	NULL
,	NULL
C.-H.	NULL
,	NULL
S.	NULL
Guerder	NULL
,	NULL
S.-C.	NULL
Hong	NULL
,	NULL
W.	NULL
van	NULL
Ewijk	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1996	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CIITA	NULL
)	NULL
show	NULL
tissue-specific	NULL
impairment	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
.	NULL

Immunity	NULL
4:167	NULL
.	NULL

Douhan	NULL
,	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
R.	NULL
Licberson	NULL
,	NULL
J.	NULL
H.	NULL
M.	NULL
Knoll	NULL
,	NULL
H.	NULL
Zhou	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1997	NULL
.	NULL

An	NULL
isotype-specific	NULL
activator	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
II	NULL
genes	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
class	NULL
II	NULL
transactivator	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1885	NULL
.	NULL

Zhou	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
S.	NULL
Su	NULL
,	NULL
X.	NULL
Zhang	NULL
,	NULL
J.	NULL
Douhan	NULL
II	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1997	NULL
.	NULL

CHTA-dependent	NULL
and	NULL
-independent	NULL
class	NULL
II	NULL
MHC	NULL
expression	NULL
revealed	NULL
by	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:4741	NULL
.	NULL

Nandan	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Reiner	NULL
.	NULL

1997	NULL
.	NULL

TGF-B	NULL
attenuates	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
and	NULL
reveals	NULL
an	NULL
accessory	NULL
pathway	NULL
of	NULL
IFN-y	NULL
action	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:1095	NULL
.	NULL

Chin	NULL
,	NULL
K.-C.	NULL
,	NULL
G.	NULL
G.-X	NULL
.	NULL

Li	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1997	NULL
.	NULL

Importance	NULL
of	NULL
acidic	NULL
,	NULL
proline/	NULL
serine/threonine-rich	NULL
,	NULL
and	NULL
GTP-binding	NULL
regions	NULL
in	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
transactivator	NULL
:	NULL
generation	NULL
of	NULL
transdominant-negative	NULL
mutants	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:2501	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

